Connection

Denis Guttridge to Rhabdomyosarcoma

Back to Details
This is a "connection" page, showing publications Denis Guttridge has written about Rhabdomyosarcoma.
Denis Guttridge
Connection Strength
1.738
Rhabdomyosarcoma
  1. Dysregulated Myogenesis in Rhabdomyosarcoma. Curr Top Dev Biol. 2018; 126:285-297.
    View in: PubMed
    Score: 0.590
  2. Mechanisms of impaired differentiation in rhabdomyosarcoma. FEBS J. 2013 Sep; 280(17):4323-34.
    View in: PubMed
    Score: 0.440
  3. NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell. 2008 Nov 04; 14(5):369-81.
    View in: PubMed
    Score: 0.317
  4. Target specificity, in vivo pharmacokinetics, and efficacy of the putative STAT3 inhibitor LY5 in osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma. PLoS One. 2017; 12(7):e0181885.
    View in: PubMed
    Score: 0.145
  5. Rhabdomyosarcoma: current challenges and their implications for developing therapies. Cold Spring Harb Perspect Med. 2014 Nov 03; 4(11):a025650.
    View in: PubMed
    Score: 0.120
  6. IL-4R drives dedifferentiation, mitogenesis, and metastasis in rhabdomyosarcoma. Clin Cancer Res. 2011 May 01; 17(9):2757-66.
    View in: PubMed
    Score: 0.094
  7. A selective screening platform reveals unique global expression patterns of microRNAs in a cohort of human soft-tissue sarcomas. Lab Invest. 2016 Apr; 96(4):481-91.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.